Nephrogenic fibrosing dermopathy differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Differentiating Nephrogenic fibrosing dermopathy from other Diseases== | ==Differentiating Nephrogenic fibrosing dermopathy from other Diseases== | ||
Nephrogenic fibrosing dermopathy must be differentiated from other diseases that cause [[skin]] thickening and edema such as scleredema, [[scleromyxedema]], [[eosinophilic fasciitis]], scleroderma, drug induced scleroderma, scleroderma overlap syndromes, [[diabetic]] cheiroarthropathy, [[myxedema]] | Nephrogenic fibrosing dermopathy must be differentiated from other diseases that cause [[skin]] thickening and [[edema]] such as scleredema, [[scleromyxedema]], [[eosinophilic fasciitis]], scleroderma, drug induced scleroderma, scleroderma overlap syndromes, [[diabetic]] cheiroarthropathy, [[myxedema]] and Chronic [[graft-versus-host disease]]. | ||
==References== | ==References== | ||
Revision as of 17:32, 30 July 2018
|
Nephrogenic fibrosing dermopathy Microchapters |
|
Differentiating Nephrogenic fibrosing dermopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nephrogenic fibrosing dermopathy differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Nephrogenic fibrosing dermopathy differential diagnosis |
|
FDA on Nephrogenic fibrosing dermopathy differential diagnosis |
|
CDC on Nephrogenic fibrosing dermopathy differential diagnosis |
|
Nephrogenic fibrosing dermopathy differential diagnosis in the news |
|
Blogs on Nephrogenic fibrosing dermopathy differential diagnosis |
|
Directions to Hospitals Treating Nephrogenic fibrosing dermopathy |
|
Risk calculators and risk factors for Nephrogenic fibrosing dermopathy differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
Differentiating Nephrogenic fibrosing dermopathy from other Diseases
Nephrogenic fibrosing dermopathy must be differentiated from other diseases that cause skin thickening and edema such as scleredema, scleromyxedema, eosinophilic fasciitis, scleroderma, drug induced scleroderma, scleroderma overlap syndromes, diabetic cheiroarthropathy, myxedema and Chronic graft-versus-host disease.